![Michael Jerman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Jerman
Director/Board Member at
HEDGEPATH PHARMACEUTICALS INC
Net worth: 58 559 $ as of 2026-07-30
Profile
Michael A. Jerman is currently an Independent Director at Alaunos Therapeutics, Inc. since 2025, an Independent Director at Inhibitor Therapeutics, Inc. since 2023, and Managing Partner at Hollywell Partners LLC since 2019.
Former roles include Independent Director at MIRA Pharmaceuticals, Inc. from 2023 to 2024, Independent Director at Telomir Pharmaceuticals, Inc. from 2023 to 2024, and Director at PricewaterhouseCoopers LLP from 2007 to 2019.
Education includes an MBA from the University of Oxford, undergraduate studies at the University of South Florida, and graduate studies at The University of Tampa, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-22 | 23,759 ( 0.97% ) | 44 667 $ | 2026-07-30 | |
| 2026-08-16 | 180,411 ( 0.1% ) | 13 892 $ | 2026-07-30 |
Michael Jerman active positions
| Companies | Position | Start |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Director/Board Member | 2023-05-23 |
| ALAUNOS THERAPEUTICS, INC. | Director/Board Member | 2025-07-14 |
HOLLYWELL PARTNERS LLC
 HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Corporate Officer/Principal | 2019-04-30 |
Former positions of Michael Jerman
| Companies | Position | End |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director/Board Member | 2024-11-17 |
| MIRA PHARMACEUTICALS, INC. | Director/Board Member | 2024-11-17 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Director/Board Member | 2019-07-31 |
Training of Michael Jerman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tampa, Inc.
 The University of Tampa, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
HOLLYWELL PARTNERS LLC
HOLLYWELL PARTNERS LLC Miscellaneous Commercial ServicesCommercial Services Operates as a financial company that provides strategy to enhance business growth for organization services | Commercial Services |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
- Stock Market
- Insiders
- Michael Jerman
